TB
Theravance Biopharma Inc
🇺🇸XNAS.TBPHUnited StatesHealthcare
$17.03USDdown -0.02 (-0.12%)OpenDelayed3:24 PM
Price$17.03-0.02 (-0.12%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- KYG8807B1068
- CUSIP
- G8807B106
Company
- Employees
- 90
- Headquarters
- South San Francisco, United States
- Website
- https://www.theravance.com
- CEO
- Mr. Rick E. Winningham M.B.A.
Market
- Shares outstanding
- 51.9M
- Market cap
- $884.18M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $885.21M
- EPS LTM
- $1.04
- P/E LTM
- 16.44
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $104.31M+35.11%up year on year
- Net income
- $53.81M+312.92%up year on year
- Gross margin
- 88.02%+85.96%up year on year
- Free cash flow
- $51.82M-78.83%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.